Tracking of second primary melanomas in vemurafenib-treated patients Journal Article

  

Authors:	Dalle, S.; Poulalhon, N.; Debarbieux, S.; Zaharia, D.; Mihm, M. C.; Lacouture, M. E.; Rosen, A.; Marghoob, A. A.; Busam, K. J.; Depaepe, L.; Bringuier, P. P.; Richez, P.; Baurain, J. F.; Bressac-de Paillerets, B.; Balme, B.; Thomas, L.
Article Title:	Tracking of second primary melanomas in vemurafenib-treated patients
Keywords:	adult; aged; gene mutation; major clinical study; cancer patient; genetic analysis; melanoma; genetic association; genotype; epiluminescence microscopy; oncogene; arf protein; cyclin dependent kinase inhibitor 2a; microphthalmia associated transcription factor; cyclin dependent kinase 4; arf gene; cdkn2a gene; vemurafenib; mitf gene; cdk4 gene; secondary primary melanoma
Journal Title:	JAMA Dermatology
Volume:	149
Issue:	4
ISSN:	2168-6068
Publisher:	American Medical Association
Date Published:	2013-04-01
Start Page:	488
End Page:	490
Language:	English
DOI:	10.1001/jamadermatol.2013.21
PROVIDER:	scopus
PUBMED:	23715012
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84876865943&partnerID=40&md5=617f491715746ff733e904bed5b7c4af
Notes:	--- - "Export Date: 3 June 2013" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/41200